Results
189
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
189 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
CRE | UK£5.34 | -1.3% | 16.5% | UK£838.3m | UK£6.67 | PE5.3x | E-0.3% | 5.0% | ||
QDMI | US$3.85 | 20.3% | 42.6% | US$1.1b | n/a | PE1038.9x | n/a | n/a | ||
HCI | US$107.41 | 1.4% | 100.1% | US$1.1b | US$138.75 | PE7.6x | E1.2% | 1.5% | ||
AMSF | US$47.85 | -2.5% | -6.2% | US$918.3m | US$53.67 | PE16x | E-22.3% | 10.4% | ||
BOW | US$27.79 | -5.0% | n/a | US$908.6m | US$29.60 | PE34.9x | E35.2% | n/a | ||
IGIC | US$18.89 | 2.8% | 63.0% | US$845.2m | US$19.00 | PE7.6x | E11.4% | 0.5% | ||
ABL | US$10.59 | 7.3% | 56.4% | US$782.3m | US$14.00 | PS8.3x | E101.8% | n/a | ||
TIPT | US$19.22 | -3.7% | 15.9% | US$721.8m | n/a | PE23x | n/a | 1.2% | ||
PRA | US$14.31 | 7.6% | -22.9% | US$712.1m | US$16.75 | PB0.6x | E75.0% | 0% | ||
UVE | US$22.10 | 0.4% | 61.3% | US$624.6m | US$25.00 | PE7.6x | E-2.1% | 3.5% | ||
SFC | CA$5.68 | 0.4% | 15.9% | CA$785.9m | CA$8.67 | PE1.3x | E-72.0% | 5.7% | ||
ROOT | US$39.45 | -3.7% | 304.6% | US$569.9m | US$70.43 | PB3.9x | E35.6% | n/a | ||
GDG | AU$2.73 | -2.8% | 83.2% | AU$817.6m | AU$3.27 | PE139x | E41.7% | 0.7% | ||
CRD.B | US$10.81 | 0.4% | 22.1% | US$553.6m | US$11.00 | PE23.2x | E44.0% | 2.6% | ||
ACIC | US$11.05 | -1.4% | 27.9% | US$547.4m | US$15.00 | PE7.4x | E6.0% | 0% | ||
AMBC | US$11.19 | 0.2% | -9.6% | US$528.5m | US$17.00 | PE7.1x | E-94.9% | n/a | ||
UFCS | US$20.69 | -0.9% | 2.8% | US$527.5m | US$19.00 | PE14.3x | S9.2% | 3.1% | ||
CSN | UK£2.53 | -4.3% | -9.6% | UK£382.0m | UK£3.42 | PE76.4x | E11.8% | 9.5% | ||
GLRE | US$13.96 | 0.3% | 25.1% | US$492.4m | n/a | PE7.5x | n/a | n/a | ||
SBRE | UK£1.45 | -1.6% | -3.6% | UK£359.2m | UK£2.00 | PE12.2x | E12.6% | 3.5% | ||
DGIC.A | US$14.47 | -5.6% | -0.8% | US$478.3m | US$14.25 | PE66.1x | E56.2% | 4.8% | ||
GBLI | US$32.75 | 3.6% | -4.5% | US$447.0m | US$55.00 | PE12.9x | E8.0% | 4.3% | ||
HIPO | US$18.15 | 0.1% | 104.2% | US$446.1m | US$25.00 | PS1.5x | E83.6% | n/a | ||
HRTG | US$15.96 | 2.2% | 160.4% | US$442.3m | US$12.50 | PE8.2x | E15.2% | 0% |